Cape Investment Advisory, Inc. Procept Bio Robotics Corp Transaction History
Cape Investment Advisory, Inc.
- $274 Billion
- Q2 2025
A detailed history of Cape Investment Advisory, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Cape Investment Advisory, Inc. holds 14 shares of PRCT stock, worth $486. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14Holding current value
$486% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
290Shares Held
45.3MCall Options Held
236KPut Options Held
91.9K-
Vanguard Group Inc Valley Forge, PA5.25MShares$182 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$121 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.16MShares$74.9 Million0.04% of portfolio
-
Chicago Capital, LLC1.57MShares$54.5 Million1.39% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.53MShares$53 Million0.06% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.55B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...